Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoling Xu

Showing results (21-30 of 427) with videos related to

Pageof 43
Sort By:
Frontiers in Oncology|October 12, 2020
Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural MesotheliomaXiaoling Xu, Lei Cheng, Yun Fan, et al.
Medicine|March 1, 2019
Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinomaXiao He, Xiaoling Xu, Guanxia Zhu, et al.
ACS Applied Bio Materials|January 13, 2022
Magnetic Iron Oxide Nanoparticles Immobilized with Sugar-Containing Poly(ionic liquid) Brushes for Efficient Trapping and Killing of BacteriaMei Hong, Ziyue Miao, Xiaoling Xu, et al.
Expert Review of Vaccines|March 26, 2021
Towards customized cancer vaccines: a promising filed in personalized cancer medicineXiaoling Xu, Zichao Zhou, Hui Li, et al.
Frontiers in Surgery|August 22, 2022
Copper-containing nanoparticles: Mechanism of antimicrobial effect and application in dentistry-a narrative reviewXinru Ma, Shiyu Zhou, Xiaoling Xu, et al.
International Journal of Nanomedicine|July 8, 2025
Nanodrug Delivery Systems for Direct Clearance or Neutralization of LPSLu Chen, Ran Pan, Xiaoling Xu, et al.
Frontiers in Pharmacology|December 27, 2023
Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired compound mutations ALK L1196M and D1203NNa Li, Huihui Li, Ding Wang, et al.
International Journal of Cancer|January 11, 2018
The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancerXiaoling Xu, Zhiyu Huang, Lei Zheng, et al.
Medicine|February 27, 2018
Percutaneous treatment for silicosis-induced pulmonary artery stenosis: A case report and review of the literatureRuifeng Zhang, Guofeng Ma, Xiaoling Xu, et al.
Polymers|April 11, 2019
Preparation and Characterization of Graphene Oxide-Modified Sapium sebiferum Oil-Based Polyurethane Composites with Improved Thermal and Mechanical PropertiesGuiying Wu, Xiaoling Xu, Xin He, et al.
Pageof 43

Showing results (21-30 of 427) with videos related to

Sort By:
Pageof 43
Frontiers in Oncology|October 12, 2020
Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural MesotheliomaXiaoling Xu, Lei Cheng, Yun Fan, et al.
Medicine|March 1, 2019
Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinomaXiao He, Xiaoling Xu, Guanxia Zhu, et al.
ACS Applied Bio Materials|January 13, 2022
Magnetic Iron Oxide Nanoparticles Immobilized with Sugar-Containing Poly(ionic liquid) Brushes for Efficient Trapping and Killing of BacteriaMei Hong, Ziyue Miao, Xiaoling Xu, et al.
Expert Review of Vaccines|March 26, 2021
Towards customized cancer vaccines: a promising filed in personalized cancer medicineXiaoling Xu, Zichao Zhou, Hui Li, et al.
Frontiers in Surgery|August 22, 2022
Copper-containing nanoparticles: Mechanism of antimicrobial effect and application in dentistry-a narrative reviewXinru Ma, Shiyu Zhou, Xiaoling Xu, et al.
International Journal of Nanomedicine|July 8, 2025
Nanodrug Delivery Systems for Direct Clearance or Neutralization of LPSLu Chen, Ran Pan, Xiaoling Xu, et al.
Frontiers in Pharmacology|December 27, 2023
Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired compound mutations ALK L1196M and D1203NNa Li, Huihui Li, Ding Wang, et al.
International Journal of Cancer|January 11, 2018
The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancerXiaoling Xu, Zhiyu Huang, Lei Zheng, et al.
Medicine|February 27, 2018
Percutaneous treatment for silicosis-induced pulmonary artery stenosis: A case report and review of the literatureRuifeng Zhang, Guofeng Ma, Xiaoling Xu, et al.
Polymers|April 11, 2019
Preparation and Characterization of Graphene Oxide-Modified Sapium sebiferum Oil-Based Polyurethane Composites with Improved Thermal and Mechanical PropertiesGuiying Wu, Xiaoling Xu, Xin He, et al.
Pageof 43